These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 16944273)
21. In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review. Rehan S; Aye K Clin Exp Ophthalmol; 2020 Jan; 48(1):98-116. PubMed ID: 31525261 [TBL] [Abstract][Full Text] [Related]
22. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP). Bertario L; Bandello F; Rossetti C; Sala P; Fortini E; Spinelli P; Gennari L; Pietroiusti M; Presciuttini S Eur J Cancer Prev; 1993 Jan; 2(1):69-75. PubMed ID: 8381318 [TBL] [Abstract][Full Text] [Related]
24. Assessment of the value of congenital hypertrophy of the retinal pigment epithelium as an ocular marker for familial adenomatous polyposis coli. Hickey-Dwyer MU; Willoughby CE Eye (Lond); 1993; 7 ( Pt 4)():562-4. PubMed ID: 8253239 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of skin lesions in familial adenomatous polyposis: a marker for presymptomatic diagnosis? Burger B; Cattani N; Trueb S; de Lorenzo R; Albertini M; Bontognali E; Itin C; Schaub N; Itin PH; Heinimann K Oncologist; 2011; 16(12):1698-705. PubMed ID: 22135120 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of fundus examination in familial adenomatous polyposis. Tiret A; Taiel-Sartral M; Tiret E; Laroche L Br J Ophthalmol; 1997 Sep; 81(9):755-8. PubMed ID: 9422927 [TBL] [Abstract][Full Text] [Related]
27. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Berk T; Cohen Z; McLeod RS; Parker JA Dis Colon Rectum; 1988 Apr; 31(4):253-7. PubMed ID: 2896112 [TBL] [Abstract][Full Text] [Related]
28. Fluorescein angiographic features of the congenital hypertrophy of the retinal pigment epithelium in the familial adenomatous polyposis. Touriño R; Rodríguez-Ares MT; López-Valladares MJ; Gómez-Ulla F; Gómez-Torreiro M; Capeans C Int Ophthalmol; 2005; 26(1-2):59-65. PubMed ID: 16779566 [TBL] [Abstract][Full Text] [Related]
30. Identification of APC exon 15 mutations in families suspected of familial adenomatous polyposis (FAP). Kirchhoff T; Zajac V; Krizan P; Repiská V; Stevurková V; Friedl W Folia Biol (Praha); 1997; 43(5):203-9. PubMed ID: 9595262 [TBL] [Abstract][Full Text] [Related]
31. Congenital hypertrophy of the retinal pigment epithelium associated with familial adenomatous polyposis. Santos A; Morales L; Hernandez-Quintela E; Jiménez-Sierra JM; Villalobos JJ; Panduro A Retina; 1994; 14(1):6-9. PubMed ID: 8016465 [TBL] [Abstract][Full Text] [Related]
32. Ophthalmoscopy for congenital hypertrophy of the retinal pigment epithelium (CHRPE) in patients with sporadic colorectal carcinoma. Hartvigsen A; Myrhøj T; Bülow S; Børme KK; Søndergaard JO; Højgaard-Olsen K; Bernstein I Int J Colorectal Dis; 1995; 10(3):138-9. PubMed ID: 7561429 [TBL] [Abstract][Full Text] [Related]
33. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Romania A; Zakov ZN; McGannon E; Schroeder T; Heyen F; Jagelman DG Ophthalmology; 1989 Jun; 96(6):879-84. PubMed ID: 2544842 [TBL] [Abstract][Full Text] [Related]
34. The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE). Deibert B; Ferris L; Sanchez N; Weishaar P Am J Ophthalmol Case Rep; 2019 Sep; 15():100524. PubMed ID: 31384696 [TBL] [Abstract][Full Text] [Related]
35. Pigmented ocular fundus lesions in the inherited gastrointestinal polyposis syndromes and in hereditary nonpolyposis colorectal cancer. Traboulsi EI; Maumenee IH; Krush AJ; Giardiello FM; Levin LS; Hamilton SR Ophthalmology; 1988 Jul; 95(7):964-9. PubMed ID: 2845322 [TBL] [Abstract][Full Text] [Related]
36. The most frequent APC mutations among Slovak familial adenomatous polyposis patients. Adenomatous polyposis coli. Zajac V; Kovác M; Kirchhoff T; Stevurková V; Tomka M Neoplasma; 2002; 49(6):356-61. PubMed ID: 12584582 [TBL] [Abstract][Full Text] [Related]
37. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Caspari R; Olschwang S; Friedl W; Mandl M; Boisson C; Böker T; Augustin A; Kadmon M; Möslein G; Thomas G Hum Mol Genet; 1995 Mar; 4(3):337-40. PubMed ID: 7795585 [TBL] [Abstract][Full Text] [Related]
38. The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment. Kartheuser A; Detry R; West S; Coppens JP; Gribomont AC; Hoang P; Melange M; Vanheuverzwyn R; Verellen-Dumoulin C; Burn J Acta Gastroenterol Belg; 1995; 58(2):252-66. PubMed ID: 7571988 [TBL] [Abstract][Full Text] [Related]
39. Optical coherence tomography findings of pigmented fundus lesions in familial adenomatous polyposis. Tzu JH; Cavuoto KM; Villegas VM; Dubovy SR; Capo H Ophthalmic Surg Lasers Imaging Retina; 2014; 45(1):69-70. PubMed ID: 24266367 [TBL] [Abstract][Full Text] [Related]